Get the Stockscreener App
31.22
0.54%
0.1692
After Hours:
31.21
-0.0097
-0.03%
Roundhill Glp 1 Weight Loss Etf stock is traded at $31.22, with a volume of 31,255.
It is up +0.54% in the last 24 hours and down -0.82% over the past month.
See More
Previous Close:
$31.05
Open:
$31.07
24h Volume:
31,255
Relative Volume:
1.44
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+1.20%
1M Performance:
-0.82%
6M Performance:
-3.60%
1Y Performance:
+29.70%
1-Day Range:
$31.07
$31.45
1-Week Range:
$29.88
$31.45
52-Week Range:
$23.22
$37.15
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Company Profile
Name
Roundhill Glp 1 Weight Loss Etf
Sector
Industry
Phone
-
Address
-
Compare OZEM vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OZEM
Roundhill Glp 1 Weight Loss Etf
|
31.22 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
366.79 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
745.64 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
749.14 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
289.09 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
717.54 | 124.43B | 0 | 0 | 0 | 0.00 |
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Latest News
GLP-1 Drug Giants Race to Go Global With Their Obesity Pills: ETFs to Gain - The Globe and Mail
485BPOS: Post-effective amendment - Moomoo
3 Ways to Invest in the Growing GLP-1 Weight Loss Market - MarketBeat
Stock List: Research Stocks from Around the World - GuruFocus
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
OZEM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
OZEM Stock Price, News & Analysis - Stock Titan
Can You Buy Ozempic Stock in 2026? - The Motley Fool
FDA Approves NVO's Increased Wegovy Dosage: Broaden Your Portfolio With These Healthcare ETFs - Bitget
FDA Clears NVO's Higher Dose of Wegovy: Diversify With These Health ETFs - The Globe and Mail
Discipline and Rules-Based Execution in OZEM Response - Stock Traders Daily
Here are the quant ratings of OZEM’s top holdings amid Novo's selloff - MSN
OZEM stock: What the Ratings say (OZEM:NASDAQ) - Seeking Alpha
ETFs with Pfizer Inc. ( PFE ) Exposure - ETF Database
Behavioral Patterns of OZEM and Institutional Flows - Stock Traders Daily
Roundhill GLP-1 & Weight Loss ETF (NASDAQ:OZEM) Short Interest Up 47.1% in January - Defense World
How to Invest in GLP-1 Stocks in 2026 - The Motley Fool
(OZEM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Healthcare ETFs to Watch as Novo Nordisk Tumbles on Poor Sales Outlook - The Globe and Mail
NVO Receives FDA Approval for MASH Therapy: ETFs Expected to Benefit - intellectia.ai
OZEM Vs. THNR: Which Is The Better ETF In The GLP-1 And Weight Loss Space? - Seeking Alpha
EXCLUSIVE: Trump 'Amplified' Several Investing Themes – ETF CEO Picks 3 Sectors Benefitting The Most - Benzinga
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All - MarketBeat
New Year, New Strategy: Navigating Weight Loss ETFs - ETF Database
Insiders Bullish on Certain Holdings of OZEM - Nasdaq
How Roundhill Etf Trust Glp-1 & Weight Loss Etf (OZEM) Affects Rotational Strategy Timing - Stock Traders Daily
The Obesity Pill Rush: Healthcare ETFs to Gain as FDA Nods to Novo Drug - The Globe and Mail
6 Top-Performing ETF Areas of Last Week - sharewise.com
(OZEM) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Best-Performing ETFs of November - TradingView — Track All Markets
Roundhill Glp-1 & Weight Loss ETF (OZEM) stock price, news, quote and history - Yahoo Finance UK
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk - Benzinga
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in - TradingView
Why (OZEM) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Roundhill Glp 1 Weight Loss Etf Stock (OZEM) Financials Data
There is no financial data for Roundhill Glp 1 Weight Loss Etf (OZEM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.90%
0.20%
Cap:
|
Volume (24h):